OUR MISSION
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the greatest morbidity and mortality. We are developing oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications, unlocking new treatment options for patients who are underserved by existing therapies. You can read more about our work here.
OUR TEAM

Ade Adeboye
Director, Clinical Development

Shauna Anderson
Associate Director, Quality

Kelly Barghausen
Director, Regulatory Affairs

Eric Bashkoff
Senior Software Engineer

Yolanda Bell
Senior Director, Supply Chain

Lisa Blackburn
Clinical Data Associate

Keely Carmack
Medical Writer

Matt Cascino
SVP, Clinical Development

Nicholas Cozzi-Krumlauf
Clinical Research Associate

Courtney Cupples
Chief Commercial Officer

Kunle Demuren
Associate, Clinical Operations

Ben Dormitorio
Principal Biostatistician

Julianne Dragan
Senior Manager, Clinical Quality

Lisa Dyer
Associate Director, Clinical Operations

Avanti Ghanekar
Senior Director, Clinical Development

Derek Gonzalez
Clinical Research Associate

Jacob Gordon
Director, Clinical Operations

Sasha Goriounova
Manager, Clinical Development

Heather Greene
Director, Statistical Programming

Matt Griffith
Associate, Business Operations

Austin Gromatzky
SVP, Strategy & Business Development

Janhavi Haldankar
Associate Director, Safety and Pharmacovigilance

Ryan Hampton
Senior Manager, Supply Chain

Adam Harvey
Associate Director, Clinical Development

Dan Hazen
Controller

Daniel Herz-Roiphe
Chief Operating Officer

Whitney Holmes
Conference Planner & Executive Assistant to the CEO

Megan Huey
Head of People

Noriko Iikuni
VP, Clinical Development

Nasif Islam
Director, Strategy & Business Development

Anna Johnson
Senior Clinical Research Associate

Brendan Johnson
SVP, Early Development

Scott Jones
VP, Clinical Operations

Brian Junio
Senior Clinical Research Associate

Casandra Kigundu
Senior Manager, Regulatory Affairs

George Kokkines
General Counsel

Beth Lang
SVP, Regulatory Affairs & Pharmacovigilance

Debbie Lee
Associate Director, Accounting

Elizabeth Lewkowicz
Office Manager & Executive Assistant

Rob Livingston
SVP, CMC

Pete Livingstone
Senior Manager, Clinical Operations

Valentina Losada
Associate, Business Operations

Tyler Massaro
Director, Biostatistics

Lisa McConnachie
Associate Director, Nonclinical Development

Jenny McDaniel
Director, Data Management

Scott Mitchell
Senior Director, Analytical Development

Paul Mudd
Chief Development Officer

Martha O'Brien
Associate Director, Statistical Programming

Malhar Patel
Senior Director, Clinical Operations

Sergey Pavlenko
Director, Clinical Operations

Sabrina Pogrebivsky
Manager, Clinical Operations

Alissa Respet
Associate Director, Quality Systems

Lindsey Rios
SVP, Program Management & Clinical Operations

Katharina Shaw
VP, Medical Affairs & Head of Dermatology Strategy

Denise Shortino
VP, Biometrics

Jeff Slowick
Associate Director, Analytical Development

Taryn Smith
Patient Engagement Manager

Bruce Stevens
SVP, Quality

Christin Thompson
Senior Clinical Research Associate

David Tromblay
Senior Associate, Quality

Drew Webster
Director, Clinical Operations

Flora Wong
Associate Director, Supply Chain

Frank Zhang
Senior Director, Drug Product Development & Manufacturing

Ben Zimmer
Chief Executive Officer

Ben Zimmer
Chief Executive Officer

Paul Mudd
Chief Development Officer

Courtney Cupples
Chief Commercial Officer

Daniel Herz-Roiphe
Chief Operating Officer

Austin Gromatzky
SVP, Strategy & Business Development

Frank Torti
Executive Chairman

Irena Melnikova
Director

Eric Venker
Director